Related Experiment Videos
Improving SH3 domain ligand selectivity using a non-natural scaffold.
J T Nguyen1, M Porter, M Amoui
1Program in Biophysics, University of California, San Francisco 94143-0450, USA.
Chemistry & Biology
|July 25, 2000
Summary
Researchers developed novel peptide-peptoid hybrid ligands that precisely target specific Src homology 3 (SH3) domains. These advanced ligands offer improved selectivity, overcoming a key challenge in developing SH3 domain inhibitors.
Area of Science:
- Molecular Biology
- Biochemistry
- Drug Discovery
Background:
- Src homology 3 (SH3) domains recognize PxxP motifs, but exhibit limited specificity due to cross-reactivity.
- N-substituted residues (peptoids) can replace prolines in PxxP motifs, introducing a novel specificity mechanism.
Purpose of the Study:
- To investigate the impact of combining peptoid substitutions with flanking sequences on SH3 ligand affinity and specificity.
- To develop highly selective SH3 domain ligands using peptide-peptoid hybrid scaffolds.
Main Methods:
- Systematic variation of peptoid substitutions and flanking sequences.
- Affinity and specificity testing of generated ligands against a panel of SH3 domains.
- Assessment of the ability of novel ligands to disrupt natural SH3-mediated interactions.
Main Results:
- Ligand affinity and specificity were successfully tuned by altering peptoid substitutions and flanking sequences.
- High-affinity ligands lacking the canonical PxxP motif were generated through multiple peptoid substitutions.
- These novel ligands demonstrated potent disruption of natural SH3-mediated interactions.
Conclusions:
- Peptide-peptoid hybrid scaffolds provide significantly enhanced SH3 domain selectivity.
- These findings overcome a major hurdle in designing selective SH3 domain inhibitors.
- The developed compounds are promising leads for orthogonal SH3 inhibitors and tools for dissecting signaling pathways.